Elan Corp. plc announced Thursday it has reached a joint-venture agreement with Parke Davis UK to market a range ofElan-developed products in the U.K.
The venture, called Elan Pharma Ltd., adds to the existingmarketing collaboration between the two companies in Ireland.
Elan of Athlone, Ireland, also announced it expects to soonpublish "impressive" Phase II data on its drug for multiplesclerosis in the medical journal Neurology.
(c) 1997 American Health Consultants. All rights reserved.